Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases

Recent Patents on Cardiovascular Drug Discovery

Volumn 2, Issue 2, 2007, Pages 147-151

  Vecchione, Lucia ^a   Gargiul, Elisa ^b   Borgiani, Paola ^a   Predazzi, Irene ^a   Mango, Ruggiero ^a   Romeo, Francesco ^a,d   Magnani, Mauro ^c   Novelli, Giuseppe ^a,d,e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b DIATHEVA srl ^*  (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiovascular diseases; Gene test; Genomic biomarker; LOX 1; LOXIN; OLR1; oxLDL; SNP

Indexed keywords

GENOMIC DNA; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

3' UNTRANSLATED REGION; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRON; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; GENETIC MARKERS; HUMANS; SCAVENGER RECEPTORS, CLASS E;

EID: 34250703150     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489007780832506     Document Type: Article

References (37)

1. Binder CJ, Chang MK, Shaw PX, et al. Innate and acquired immunity in atherogenesis. Nat Med 2002; 8:1218-1226.
2. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 8: 1211-1217.
3. Suzuki T, Kohno H, Hasegawa A, et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 2002; 35: 347-353.
4. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002; 95: 89-100.
5. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73-77.
6. Chen M, Kakutani M, Naruko T, et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001; 282: 153-158.
7. Kataoka H, Kume N, Miyamoto S, et al. Oxidized LDL modulates Bax/ Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21: 955-960.
8. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 1998; 334: 9-13.
9. Xie Q, Matsunaga S, Shi X, et al. Refolding and characterization of the functional ligand-binding domain of human lectin-like oxidized LDL receptor. Protein Expr Purif 2003; 32: 68-74.
10. Chen M, Sawamura T. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1). J Mol Cell Cardiol 2005; 39: 553-561.
11. Syud, F., Zhao, M., Torres, A.: WO06020743 (2006).
12. Syud, F., Zhao, M., Torres, A.: US2006034761 (2006).
13. Chen M, Narumiya S, Masaki T, Sawamura T. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J 2001; 355: 289-296.
14. Mango R, Clementi F, Borgiani P, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003; 40: 933-936.
15. Chen Q, Reis SE, Kammerer C, et al. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 2003; 107: 3146-3151.
16. Mango R, Biocca S, del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 2005; 97: 152-158.
17. Novelli, G., Mango, R., Romeo, F., Lauro, R., Clementi, F.: WO06137101 (2006).
18. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303: 247-250.
19. Puccetti L, Pasqui AL, Bruni F, et al. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment. Int J Cardiol 2006.
20. Day JP, Bergstrom D, Hammer RP, Barany F. Nucleotide analogs facilitate base conversion with 3′ mismatch primers. Nucleic Acids Res 1999; 27: 1810-1818.
21. Culver, K.W., Zhu, J., Lilleberg, S.: WO07016532 (2007).
22. Latorra D, Campbell K, Wolter A, Hurley JM. Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers. Hum Mutat 2003; 22: 79-85.
23. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001; 295: 540-544.
24. Valle D. Genetics, individuality, and medicine in the 21st century. Am J Hum Genet 2004; 74: 374-381.
25. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001; 357: 709-712.
26. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000; 343: 141-144.
27. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 2006; 8: 395-400.
28. Hirschhom JN, Lohmueller K, Byme E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61.
29. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003; 361: 567-571.
30. Clarke R, Xu P, Bennett D, et al. International Study of Infarct Survival (ISIS) Collaborators. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2006; 2: e107.
31. Novelli G, Borgiani P, Mango R, Romeo F, Mehta JL. OLR1 gene and coronary artery disease/acute myocardial infarction: replication in an independently collected sample. Eur J Hum Genet 2006;14: 894-895.
32. Novelli G, Borgiani P, Mango R, Lauro R, Romeo F. Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Nutr Metab Cardiovasc Dis 2007; 17:e7-8.
33. Ohmori R, Momiyama Y, Nagano M, et al. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 2004; 27: 641-644.
34. Trabetti E, Biscuola M, Cavallari U, et al. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 2006; 14: 127-130.
35. Hattori H, Sonoda A, Sato H, et al. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res 2006; 1121: 246-249.
36. Puccetti L, Pasqui AL, Pastorelli M, et al. 3′UTRT polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects. Atherosclerosis 2005; 183: 322-328.
37. Sentinelli F, Filippi E, Fallarino M, et al. The 3′-UTR C > T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutr Metab Cardiovasc Dis 2006; 16: 345-352.